Triphala Ghrita tulle (Vikeshika) and betadine tulle (Vikeshika) dressing in the management of Dushta Vrana (Infected wound).

Randomised comparative clinical study to evaluate the efficacy of Triphala Ghrita tulle (Vikeshika) and betadine tulle (Vikeshika) dressing in the management of Dushta Vrana (Infected wound).

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029331

Enrollment

Registered

2020-11-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T07- Unspecified multiple injuries

Interventions

Intervention1: Randomised comparative clinical study to evaluate the efficacy of Triphala Ghrita tulle (Vikeshika) and betadine tulle (Vikeshika) dressing in the management of Dushta Vrana (Infected w

Eligibility

Inclusion criteria

Inclusion criteria: Patient having infected wound. Wound size 3 cm x 3 cm to 15 cm x 15 cm. Infected wound due to trauma and accident. Post-operative all infected wound Age group 18 yrs to 60 yrs. Gangrenous wound Diabetic infected wound

Exclusion criteria

Exclusion criteria: Neoplastic ulcer Other associated disorders e.g. gout, renal failure Liver failure; Bed sores Varicose ulcer HIV & and immunocompromised patients

Design outcomes

Primary

Measure	Time frame
Triphala Ghrita tulle (Vikeshika) is effective in the management of Dushtavrana. (Infected wound)Timepoint: 2 weeks	—

Secondary

Measure	Time frame
Triphala Ghrita tulle (Vikeshika) is not effective in the management of Dushtavrana(Infected wound) There is significant difference in the efficacy of Triphala Ghrita tulle (Vikeshika) and Betadine tulle (Vikeshika) in the management of DushtavranaTimepoint: 1 yr	—

Countries

India

Contacts

Public ContactAmrita Bhausaheb Dandekar

Sumatibhai shah ayurved mahavidyalya malwadi hadapasar pune

drrakale@gmail.com9822244893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026